Coronary Microvascular Dysfunction and Diastolic Load Correlate With Cardiac Troponin T Release Measured by a Highly Sensitive Assay in Patients With Nonischemic Heart Failure

Seiji Takashio(Kumamoto University), Hisao Ogawa(Jikei University School of Medicine), Kenichi Tsujita(British Heart Foundation), Tomoko Tanaka(Kumamoto University), Seiji Hokimoto(Omuta hospital), Sunao Kojima(Kumamoto University), Seigo Sugiyama(Kumamoto University), Koichi Kaikita(Kumamoto University), Megumi Yamamuro(IRYO Sosei University), Eiichiro Yamamoto(Mie University), Yasuhiro Izumiya(Kumamoto University), Shinji Tayama(Saiseikai Kumamoto Hospital)
Journal of the American College of Cardiology
May 1, 2013
10.1016/j.jacc.2013.03.065
Cited by 89

Related Papers

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial
|The Lancet|2017|881
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|753
Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention
|Journal of the American College of Cardiology|2015|449